536 RANIDO trial: Racotumomab-alum vaccine, Nimotuzumab or...

European Journal of Cancer 2015 / 09 Vol. 51

536 RANIDO trial: Racotumomab-alum vaccine, Nimotuzumab or Docetaxel as switch maintenance therapy for advanced NSCLC

Hernandez, M., Neninger, E., Santiesteban, E., Ortiz, R., Amador, R., Bello, L., Acosta, S., Flores, Y., Cala, M., Martínez, O., Calana, A., Pichs, G., Robaina, M., Sánchez, L., Viada, C., Valdez, A.,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)30337-9
Date:
September, 2015
File:
PDF, 59 KB
english, 2015
Conversion to is in progress
Conversion to is failed